期刊文献+

局部枸橼酸钠抗凝在单重血浆置换中的临床应用 被引量:8

Regional anticoagulation with sodium citrate in plasma exchange
原文传递
导出
摘要 探讨建立一种简便易行单重血浆置换的枸橼酸钠抗凝参考方案。选择于北京大学第一医院肾内科就诊并接受局部枸橼酸钠抗凝单重血浆置换治疗的患者为研究对象,共53例次,根据枸橼酸钠抗凝的方式分为A组(n=9)和B组(n=10),回顾性分析患者临床资料。无一例因滤器跨膜压(TMP)达到上限或动静脉小壶凝血而提前终止治疗。在治疗过程中,B组患者体内离子钙水平显著高于A组(P﹤0.05),且更接近正常目标值,提示B组方案更为安全有效。本研究结果提示局部枸橼酸钠抗凝方案简便易行,抗凝效果理想,无严重不良事件发生,可保证单重血浆置换安全有效地进行。
作者 吴道诩 贾晓玉 谭颖 于重燕 程叙扬 金其庄 Wu Daoxu;Jia Xiaoyu;Tan Ying;Yu Chongyan;Cheng Xuyang;Jin Qizhuang(Department of Nephrology,Peking University First Hospital,Institute of Nephrology,Peking University,Key Lab of Renal Disease,Ministry of Health of China,Key Laboratory of Chronic Kidney Disease Prevention and Treatment,Ministry of Education of China,Beijing 100034,China;Department of Nephrology,the Affiliated Yantai Yuhuangding Hospital of Qingdao University,Yantai City of Shandong Province 264000,China)
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2020年第11期866-869,共4页 Chinese Journal of Nephrology
  • 相关文献

参考文献1

二级参考文献11

  • 1王质刚.血液净化学[M].第3版.北京:北京科学技术出版社,2011.
  • 2Tolwani A, Wille KM. Advances in continuous renal replacement therapy: citrate anticoagulation update[J]. Blood Purif, 2012, 34: 88-93.
  • 3Kidney Disease Improving Global Outcomes (KDIGO). KDIGO clinical practice guideline for acute kidney injury[J]. Kidney Int, 2012, 2: 1-138.
  • 4Kutsogiannis DJ, Mayers I, Chin WD, et al. Region citrate anticoagulation in continuous venovenous hemodiafihration[J]. Am J Kidney Dis, 2000, 35: 802-811.
  • 5Dhondt A, Vanholder R, Tielemans C, et al. Effect of regional citrate anticoagulation on leucopenia, complement activation, and expression of leukocyte surface molecules during hemodialysis with unmodified cellulose membrane[J]. Nephron, 2000, 85: 334-342.
  • 6Lanckohr C, Hahnenkamp K, Boschin M. Continuous renal replacement therapy with regional citrate anticoagulation: do we really know the details?[J]. Curr Opin Anaesthesiol, 2013, 26: 428-437.
  • 7Mazuski JE, Bailey JA, Shapiro MJ. Intensive insulin therapy in critically ill patients[J]. N Engl J Med, 2002, 346: 1586- 1588.
  • 8American Diabetes Association (ADA). Executive Summary: Standards of Medical Care in Diabetes-2014[J]. Diabetes Care, 2014, 37 Suppl 1: S14-S80.
  • 9Godden J, Spexarth F, Dahlgren M. Standardization of continuous renal - replacement therapy fluids using a commercial product[J]. Am J Health Syst Pharm, 2012, 69:786 -793.
  • 10Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy[J]. Intensive Care Med, 2012, 38:20 -28.

共引文献14

同被引文献63

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部